Neuberger Berman Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.78M | Buy |
180,289
+41,990
| +30% | +$1.81M | 0.01% | 849 |
|
|
2025
Q1 | $4.78M | Buy |
+138,299
| New | +$4.78M | ﹤0.01% | 942 |
|
|
2021
Q3 | – | Sell |
-4,183
| Closed | -$250K | – | 1760 |
|
|
2021
Q2 | $250K | Buy |
+4,183
| New | +$250K | ﹤0.01% | 1657 |
|
|
2021
Q1 | – | Sell |
-4,083
| Closed | -$284K | – | 1753 |
|
|
2020
Q4 | $284K | Buy |
+4,083
| New | +$284K | ﹤0.01% | 1518 |
|
|
2020
Q1 | – | Sell |
-6,500
| Closed | -$228K | – | 1524 |
|
|
2019
Q4 | $228K | Buy |
+6,500
| New | +$228K | ﹤0.01% | 1441 |
|